Last updated: February 25, 2026
What are the key excipients used in GAVISCON?
GAVISCON’s formulation primarily includes the following excipients:
- Alginate (sodium alginate): Forms a viscous gel upon contact with gastric acid, creating a physical barrier to reflux.
- Sodium bicarbonate: Reacts with gastric acid to produce carbon dioxide, which helps the alginate gel float on the stomach contents.
- Calcium carbonate: Used in some formulations as an antacid and buffering agent.
- Other excipients: Include sweeteners (e.g., sodium saccharin), flavoring agents (e.g., lemon or mint flavorings), and preservatives to stabilize the product.
Table 1: Common excipients in GAVISCON
| Component |
Function |
Notes |
| Sodium alginate |
Gel-forming barrier |
Critical for efficacy |
| Sodium bicarbonate |
Reacts with gastric acid |
Produces CO₂, buoyancy |
| Calcium carbonate |
Antacid, buffering |
Used in some formulations |
| Sweeteners, Flavors |
Mask taste, improve compliance |
Sodium saccharin, flavor extracts |
What strategic considerations influence excipient selection?
- Efficacy Enhancement: The combination of sodium alginate and sodium bicarbonate creates a dense alginate raft that resists gastric emptying, improving symptom relief.
- Safety Profile: Excipients must have a well-established safety record, with minimal risk of adverse reactions.
- Regulatory Compliance: Ingredients must conform to pharmacopeial standards (e.g., USP, EP), simplifying approval.
- Stability: Selected excipients should stabilize the active ingredients and maintain product shelf life.
- Manufacturing Compatibility: Excipients should facilitate scalable production processes, including mixing, filling, and packaging.
How do excipient strategies influence commercial opportunities?
- Market Differentiation: Incorporating novel or improved excipients (e.g., faster-acting gelling agents) can create a unique product position.
- Formulation Innovation: Developing a liquid, syringeable, or chewable version could meet niche patient needs.
- Global Regulatory Access: Utilizing widely accepted excipients simplifies regulatory pathways across multiple markets, enhancing global reach.
- Cost Optimization: Sourcing cost-effective excipients without compromising quality supports competitive pricing.
- Patent Opportunities: Novel excipient combinations or delivery mechanisms can generate intellectual property rights, prolonging market exclusivity.
What are current patent landscapes and key innovation areas?
Patent filings for GAVISCON formulations often focus on:
- Novel alginate formulations with enhanced viscosity or bioadhesion.
- Combination formulations integrating additional synergistic excipients (e.g., probiotics, analgesics).
- Alternative delivery systems (e.g., effervescent tablets, beverage formats) that modify excipient profiles.
- Microencapsulation techniques for controlled release or targeted delivery, expanding therapeutic claims.
Major patent holders include Reckitt Benckiser and generic manufacturers, with patent expirations occurring over the next five years, signaling increased competition.
What commercial opportunities exist in excipient development?
- License-in R&D: Partner with excipient suppliers to develop proprietary formulations.
- Customization for Markets: Adapt excipient profiles to meet regional regulatory preferences or consumer trends (e.g., sugar-free, natural flavorings).
- Expanded Indications: Develop formulations with enhanced excipients suitable for other reflux or gastrointestinal conditions.
- Market Segments: Target niche markets such as pediatric, elderly, or bariatric patients with specialized excipient choices.
Key challenges in excipient strategy
- Maintaining safety and tolerability, particularly in vulnerable populations.
- Ensuring compatibility with existing formulations and manufacturing processes.
- Navigating patent landscapes while seeking innovation and differentiation.
- Balancing cost with quality to sustain profit margins.
Summary
GAVISCON’s excipient profile centers on proven, safe, and regulatory-compliant ingredients like sodium alginate and bicarbonate that support its anti-reflux mechanism. Strategic development of excipient combinations can unlock new formulation types, extend patent exclusivity, and expand market access. Innovations may include alternative delivery systems or added functionalities, aligning with consumer demands for convenience and safety.
Key Takeaways
- Sodium alginate and bicarbonate form the core excipients in GAVISCON, enabling its raft-forming mechanism.
- Excipient selection directly impacts product efficacy, safety, and regulatory approval.
- Innovation in excipient composition and delivery formats presents growth avenues.
- Patent expirations within five years could open opportunities for new formulations.
- Cost, safety, and regulatory compliance remain central to excipient strategy.
FAQs
Q1: How does sodium alginate improve GAVISCON’s performance?
It forms a viscous gel that floats on stomach contents, creating a barrier to acid reflux.
Q2: Are there opportunities to replace sodium bicarbonate in GAVISCON?
Yes, alternative buffering agents or effervescent components can be developed, provided they meet safety and efficacy standards.
Q3: What excipients are most likely to face regulatory scrutiny?
Preservatives and artificial sweeteners require careful consideration due to potential allergenicity or safety concerns.
Q4: Can excipient innovation extend GAVISCON’s patent life?
Yes, novel combinations or delivery systems involving excipients can generate new patent protections.
Q5: Which markets are most receptive to reformulated GAVISCON products?
Markets with stringent regulations and consumer preferences for natural or sugar-free formulations offer growth potential.
References
- Reckitt Benckiser. (2022). Gaviscon product monograph. Retrieved from http://www.reckitt.com
- USP. (2022). USP Dictionary of Excipients. U.S. Pharmacopeia.
- European Pharmacopoeia. (2022). Monographs on sodium alginate, sodium bicarbonate.
- PatentScope. (2023). Patent filings related to alginate-based formulations. WIPO.
- Market Research Future. (2022). Over-the-counter gastrointestinal drugs market analysis.
